Baddour LM; Infectious Diseases Society of America s Emerging Infections Network. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322:209 212. 244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230 247. doi: 10.1016/j. jinf.2004.10.016. 245. Boland JM, Chung HH, Robberts FJ, Wilson WR, Steckelberg JM, Baddour LM, Miller DV. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses. 2011;54:354 360. doi: 10.1111/j.1439-0507.2010.01884.x. 246. Smego RA Jr, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore). 2011;90:237 249. doi: 10.1097/MD.0b013e3182259d38. 247. Hoen B, Duval X. Clinical practice: infective endocarditis [published correction appears in N Engl J Med. 2013;368:2536]. N Engl J Med. 2013;368:1425 1433. doi: 10.1056/NEJMcp1206782. 248. Delahaye F. Is early surgery beneficial in infective endocarditis? A sys- tematic review. Arch Cardiovasc Dis. 2011;104:35 44. doi: 10.1016/j. acvd.2010.11.003. 249. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM. The role of valve surgery in infective endocarditis man- agement: a systematic review of observational studies that included pro- pensity score analysis. Am Heart J. 2008;156:901 909. doi: 10.1016/j. ahj.2008.06.031. 250. Desch S, Freund A, de Waha S, Eitel I, Lurz P, Stiermaier T, Fuernau G, Schuler G, Thiele H. Outcome in patients with left-sided native- valve infective endocarditis and isolated large vegetations. Clin Cardiol. 2014;37:626 633. doi: 10.1002/clc.22315. 251. Chirouze C,Alla F, FowlerVG Jr, Sexton DJ, Corey GR, ChuVH,WangA, Erpelding ML, Durante-Mangoni E, Fern ndez-Hidalgo N, Giannitsioti E, Hannan MM, Lejko-Zupanc T, Mir JM, Mu oz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B; ICE Prospective Investigators. 